PHARMAPRINT
DEAD

Serial Number

75178758

Owner

PharmaPrint Inc.

Attorney

EUGENE K. HYUN

Filing Date

Oct 8, 1996

Add to watchlist:

No watchlists yet
View on USPTO

PHARMAPRINT Trademark

Serial Number: 75178758

PHARMAPRINT is a trademark filed by PharmaPrint Inc. on October 8, 1996. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

PharmaPrint Inc. (9 trademarks)

2600 MICHELSON DRIVE, SUITE 1600
Irvine, CA 92612

Entity Type: 03

ABT Global Pharmaceutical Corp. (2 trademarks)

5 Park Plaza
Irvine, CA 92714

Entity Type: 03

Trademark Details

Filing Date

October 8, 1996

Registration Date

Not Registered

Published for Opposition

July 28, 1998

Goods & Services

pharmaceuticals and pharmaceutical preparations based on natural medicines that-- reduce the symptoms of premenstrual stress (pms), regulate the menstrual cycle, increase the production of milk in a woman who is breast feeding, and alter the amounts of the hormone that causes the production of breast milk; cause significant diarrhea, improve wound healing, reduce inflammation, reduce itching, protect the liver and are used in the treatment of arthritis; reduce diarrhea and inflammation; reduce the discomfort of painful menstrual periods, reduce joint pain and throat soreness, cause sleepiness and are therapy for bronchitis; reduce cramping pain, digestive tract distress and inflammation of the skin; improve hemorrhoids, swelling due to some causes of insufficient blood flow in veins (venous insufficiency), and varicose veins; increase resistance to infections caused by bacteria, improve the healing of superficial skin wounds, and assist the treatment of recurring infections of the respiratory and urinary tracts; promote the flow in menstruation and reduce cramping pain; reduce certain types of skin outbreaks (eczema), reduce the pain of migraine headaches and menstrual periods, and are used in the treatment of asthma and arthritis; breakdown of blood clots; reduce nausea by acting on the digestive tract; and of abnormal changes in the light sensing portion of the eye, i.e., retina; reduce stress and damage caused to the liver; are used in the treatment of cancer; and are a general tonic; reduce cramping pain, muscle and joint pain; heart conditions associated with the elderly, mild heart pain brought on by exertion (angina), and mild irregularities of the heart beat; and lower blood pressure; are used in the treatment of degenerative arthritis; reduce distress of the intestinal tract; and improve the clearing of mucus from the lungs; cause sleepiness and treats insomnia; are used in the treatment of ulcers and arthritis; reduce inflammation; and improve the clearing of mucus from the lungs; protect the liver, including against scarring (cirrhosis) and inflammation (hepatitis); are a free radical scavenger and antioxidant; reduce pain and inflammation and improve insomnia and bronchial asthma; are used in the treatment of cancer and diabetes; and in some ways act like an antioxidant; have an effect against cancer; lower blood pressure; help protect a developing fetus against damage from exposure of drugs, chemicals and certain other materials; help the body remove excess fluid through urination; are used in the treatment of asthma; improve rheumatism; and stimulate the growth of hair; promote sleepiness; calm; modify the activity of the body's immune system; and reduce elevated levels of certain fatty substances in the blood; treat cancer

Filing History

PAPER RECEIVED
Aug 2, 2002 MAIL
ABANDONMENT - NO USE STATEMENT FILED
Apr 17, 2001 ABN6
DIVISIONAL PROCESSING COMPLETE
Aug 29, 2000 DPCC
DIVISIONAL REQUEST RECEIVED
Apr 19, 2000 DRRR
SOU EXTENSION 2 GRANTED
Dec 6, 1999 EX2G
SOU EXTENSION 2 FILED
Oct 19, 1999 EXT2
SOU EXTENSION 1 GRANTED
Jun 3, 1999 EX1G
SOU EXTENSION 1 FILED
Apr 19, 1999 EXT1
NOA MAILED - SOU REQUIRED FROM APPLICANT
Oct 20, 1998 NOAM
PUBLISHED FOR OPPOSITION
Jul 28, 1998 PUBO
NOTICE OF PUBLICATION
Jun 26, 1998 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
May 12, 1998 CNSA
NON-FINAL ACTION MAILED
Jun 19, 1997 CNRT
ASSIGNED TO EXAMINER
Apr 11, 1997 DOCK